By activating both phases concurrently, the blend compresses the healing timeline
Certificate of Analysis Every AOD-9604 order from PSPeptides ships with a batch-specific Certificate of Analysis (COA) generated by an independent third-party laboratory
Disclosure of interest: Isra Hatab: nothing to disclose E-Posters - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.03 - PROGNOSIS AND OUTCOME AFTER STROKE P2260 - ESOC25-1519 OUTCOMES PREDICTORS IN CANCER PATIENTS WITH LARGE VESSEL OCCLUSION STROKE UNDERGOING MECHANICAL THROMBECTOMY Carlota Villar Rodriguez 1,2 , Diego Villagran Sancho 1,2 , Luis Manzano-Hernndez 1,2 , Blanca Pardo-Galiana 1,2 , Leire Ainz-Gmez 1,2 , Pablo Baena Palomino 1,2 , Juan Antonio Cabezas Rodriguez 1,2 , Manuel Medina-Rodriguez 1,2 , Andrs Hermosn-Gmez 1,2 , Alejandro Gonzalez Garcia 2,3 , Marta Aguilar 2,3 , Asier de Albniga-Chindurza 2,3 , Francisco Moniche 1,2 , Elena Zapata Arriaza 2,3 1 Virgen del Rocio, University Hospital
Active Ingredients (Per Vial): GHK-Cu 50mg A copper-binding tripeptide studied for its role in collagen synthesis, cellular regeneration signaling, and extracellular matrix remodeling in laboratory research models
